Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding study of E-58425 for moderate to severe dental pain
2011-002778-21Phase 2Completed
- Sponsor
- Esteve
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tramadol + celecoxib in odontalgia (6 arms), sponsored by Esteve. Primary endpoint: Analgesic efficacy. Started Oct 2011; status: completed.
02
Drugs
tramadol + celecoxib
03
Conditions
odontalgia
Beyond the preview
Go deeper on 2011-002778-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002778-21.